id	sid	tid	token	lemma	pos
dpc-2702	1	1	dermatology	dermatology	NOUN
dpc-2702	1	2	:	:	PUNCT
dpc-2702	1	3	practical	practical	ADJ
dpc-2702	1	4	and	and	CCONJ
dpc-2702	1	5	conceptual	conceptual	ADJ
dpc-2702	1	6	research	research	NOUN
dpc-2702	1	7	letter	letter	NOUN
dpc-2702	2	1	|	|	ADV
dpc-2702	2	2	dermatol	dermatol	ADJ
dpc-2702	2	3	pract	pract	NOUN
dpc-2702	2	4	concept	concept	NOUN
dpc-2702	2	5	.	.	PUNCT
dpc-2702	3	1	2023;13(2):e2023097	2023;13(2):e2023097	NUM
dpc-2702	3	2	1	1	NUM
dpc-2702	3	3	risankizumab	risankizumab	NOUN
dpc-2702	3	4	for	for	ADP
dpc-2702	3	5	the	the	DET
dpc-2702	3	6	treatment	treatment	NOUN
dpc-2702	3	7	of	of	ADP
dpc-2702	3	8	palmoplantar	palmoplantar	NOUN
dpc-2702	3	9	pustular	pustular	ADJ
dpc-2702	3	10	psoriasis	psoriasis	NOUN
dpc-2702	3	11	:	:	PUNCT
dpc-2702	3	12	a	a	DET
dpc-2702	3	13	report	report	NOUN
dpc-2702	3	14	of	of	ADP
dpc-2702	3	15	two	two	NUM
dpc-2702	3	16	cases	case	NOUN
dpc-2702	3	17	luigi	luigi	PROPN
dpc-2702	3	18	gargiulo1,2	gargiulo1,2	PROPN
dpc-2702	3	19	,	,	PUNCT
dpc-2702	3	20	carlo	carlo	PROPN
dpc-2702	3	21	alberto	alberto	PROPN
dpc-2702	3	22	vignoli1,2	vignoli1,2	PROPN
dpc-2702	3	23	,	,	PUNCT
dpc-2702	3	24	giulia	giulia	PROPN
dpc-2702	3	25	pavia1,2	pavia1,2	PROPN
dpc-2702	3	26	,	,	PUNCT
dpc-2702	3	27	alessandra	alessandra	PROPN
dpc-2702	3	28	narcisi1,2	narcisi1,2	PROPN
dpc-2702	3	29	,	,	PUNCT
dpc-2702	3	30	antonio	antonio	PROPN
dpc-2702	3	31	 	 	SPACE
dpc-2702	3	32	costanzo1,2	costanzo1,2	PROPN
dpc-2702	3	33	,	,	PUNCT
dpc-2702	3	34	chiara	chiara	X
dpc-2702	3	35	perugini1	perugini1	PROPN
dpc-2702	3	36	1	1	NUM
dpc-2702	3	37	dermatology	dermatology	NOUN
dpc-2702	3	38	unit	unit	NOUN
dpc-2702	3	39	,	,	PUNCT
dpc-2702	3	40	irccs	ircc	VERB
dpc-2702	3	41	humanitas	humanitas	NOUN
dpc-2702	3	42	research	research	NOUN
dpc-2702	3	43	hospital	hospital	NOUN
dpc-2702	3	44	,	,	PUNCT
dpc-2702	3	45	rozzano	rozzano	PROPN
dpc-2702	3	46	,	,	PUNCT
dpc-2702	3	47	milano	milano	PROPN
dpc-2702	3	48	,	,	PUNCT
dpc-2702	3	49	italy	italy	PROPN
dpc-2702	3	50	2	2	NUM
dpc-2702	3	51	department	department	NOUN
dpc-2702	3	52	of	of	ADP
dpc-2702	3	53	biomedical	biomedical	ADJ
dpc-2702	3	54	sciences	sciences	PROPN
dpc-2702	3	55	,	,	PUNCT
dpc-2702	3	56	humanitas	humanita	NOUN
dpc-2702	3	57	university	university	NOUN
dpc-2702	3	58	,	,	PUNCT
dpc-2702	3	59	pieve	pieve	PROPN
dpc-2702	3	60	emanuele	emanuele	PROPN
dpc-2702	3	61	,	,	PUNCT
dpc-2702	3	62	milano	milano	PROPN
dpc-2702	3	63	,	,	PUNCT
dpc-2702	3	64	italy	italy	PROPN
dpc-2702	3	65	key	key	ADJ
dpc-2702	3	66	words	word	NOUN
dpc-2702	3	67	:	:	PUNCT
dpc-2702	3	68	psoriasis	psoriasis	NOUN
dpc-2702	3	69	,	,	PUNCT
dpc-2702	3	70	palmoplantar	palmoplantar	NOUN
dpc-2702	3	71	pustular	pustular	ADJ
dpc-2702	3	72	psoriasis	psoriasis	NOUN
dpc-2702	3	73	,	,	PUNCT
dpc-2702	3	74	risankizumab	risankizumab	NOUN
dpc-2702	3	75	,	,	PUNCT
dpc-2702	3	76	biologics	biologic	NOUN
dpc-2702	3	77	,	,	PUNCT
dpc-2702	3	78	anti	anti	ADJ
dpc-2702	3	79	-	-	ADJ
dpc-2702	3	80	il-23	il-23	ADJ
dpc-2702	3	81	citation	citation	NOUN
dpc-2702	3	82	:	:	PUNCT
dpc-2702	3	83	gargiulo	gargiulo	PROPN
dpc-2702	3	84	l	l	NOUN
dpc-2702	3	85	,	,	PUNCT
dpc-2702	3	86	vignoli	vignoli	NOUN
dpc-2702	3	87	ca	ca	PROPN
dpc-2702	3	88	,	,	PUNCT
dpc-2702	3	89	pavia	pavia	VERB
dpc-2702	3	90	g	g	NOUN
dpc-2702	3	91	,	,	PUNCT
dpc-2702	3	92	narcisi	narcisi	ADV
dpc-2702	3	93	a	a	PRON
dpc-2702	3	94	,	,	PUNCT
dpc-2702	3	95	costanzo	costanzo	PROPN
dpc-2702	3	96	a	a	PRON
dpc-2702	3	97	,	,	PUNCT
dpc-2702	3	98	perugini	perugini	PROPN
dpc-2702	3	99	c.	c.	PROPN
dpc-2702	3	100	risankizumab	risankizumab	PROPN
dpc-2702	3	101	for	for	ADP
dpc-2702	3	102	the	the	DET
dpc-2702	3	103	treatment	treatment	NOUN
dpc-2702	3	104	of	of	ADP
dpc-2702	3	105	palmoplantar	palmoplantar	NOUN
dpc-2702	3	106	pustular	pustular	ADJ
dpc-2702	3	107	psoriasis	psoriasis	NOUN
dpc-2702	3	108	:	:	PUNCT
dpc-2702	3	109	a	a	DET
dpc-2702	3	110	report	report	NOUN
dpc-2702	3	111	of	of	ADP
dpc-2702	3	112	two	two	NUM
dpc-2702	3	113	cases	case	NOUN
dpc-2702	3	114	.	.	PUNCT
dpc-2702	4	1	dermatol	dermatol	NOUN
dpc-2702	4	2	pract	pract	PROPN
dpc-2702	4	3	concept	concept	NOUN
dpc-2702	4	4	.	.	PUNCT
dpc-2702	5	1	2023;13(2):e2023097	2023;13(2):e2023097	X
dpc-2702	5	2	.	.	X
dpc-2702	5	3	doi	doi	NOUN
dpc-2702	5	4	:	:	PUNCT
dpc-2702	5	5	https://doi.org/10.5826/dpc.1302a97	https://doi.org/10.5826/dpc.1302a97	PROPN
dpc-2702	5	6	accepted	accept	VERB
dpc-2702	5	7	:	:	PUNCT
dpc-2702	5	8	july	july	PROPN
dpc-2702	5	9	27	27	NUM
dpc-2702	5	10	,	,	PUNCT
dpc-2702	5	11	2023	2023	NUM
dpc-2702	5	12	;	;	PUNCT
dpc-2702	5	13	published	publish	VERB
dpc-2702	5	14	:	:	PUNCT
dpc-2702	6	1	april	april	PROPN
dpc-2702	6	2	2023	2023	NUM
dpc-2702	6	3	copyright	copyright	NOUN
dpc-2702	6	4	:	:	PUNCT
dpc-2702	6	5	©	©	PROPN
dpc-2702	6	6	2023	2023	NUM
dpc-2702	6	7	gargiulo	gargiulo	NOUN
dpc-2702	6	8	et	et	PROPN
dpc-2702	6	9	al	al	PROPN
dpc-2702	6	10	.	.	PUNCT
dpc-2702	7	1	this	this	PRON
dpc-2702	7	2	is	be	AUX
dpc-2702	7	3	an	an	DET
dpc-2702	7	4	open	open	ADJ
dpc-2702	7	5	-	-	PUNCT
dpc-2702	7	6	access	access	NOUN
dpc-2702	7	7	article	article	NOUN
dpc-2702	7	8	distributed	distribute	VERB
dpc-2702	7	9	under	under	ADP
dpc-2702	7	10	the	the	DET
dpc-2702	7	11	terms	term	NOUN
dpc-2702	7	12	of	of	ADP
dpc-2702	7	13	the	the	DET
dpc-2702	7	14	creative	creative	ADJ
dpc-2702	7	15	commons	common	NOUN
dpc-2702	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2702	7	17	license	license	NOUN
dpc-2702	7	18	(	(	PUNCT
dpc-2702	7	19	by	by	ADP
dpc-2702	7	20	-	-	PUNCT
dpc-2702	7	21	nc-4.0	nc-4.0	NOUN
dpc-2702	7	22	)	)	PUNCT
dpc-2702	7	23	,	,	PUNCT
dpc-2702	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2702	7	25	,	,	PUNCT
dpc-2702	7	26	which	which	PRON
dpc-2702	7	27	permits	permit	VERB
dpc-2702	7	28	unrestricted	unrestricted	ADJ
dpc-2702	7	29	noncommercial	noncommercial	ADJ
dpc-2702	7	30	use	use	NOUN
dpc-2702	7	31	,	,	PUNCT
dpc-2702	7	32	distribution	distribution	NOUN
dpc-2702	7	33	,	,	PUNCT
dpc-2702	7	34	and	and	CCONJ
dpc-2702	7	35	reproduction	reproduction	NOUN
dpc-2702	7	36	in	in	ADP
dpc-2702	7	37	any	any	DET
dpc-2702	7	38	medium	medium	NOUN
dpc-2702	7	39	,	,	PUNCT
dpc-2702	7	40	provided	provide	VERB
dpc-2702	7	41	the	the	DET
dpc-2702	7	42	original	original	ADJ
dpc-2702	7	43	authors	author	NOUN
dpc-2702	7	44	and	and	CCONJ
dpc-2702	7	45	source	source	NOUN
dpc-2702	7	46	are	be	AUX
dpc-2702	7	47	credited	credit	VERB
dpc-2702	7	48	.	.	PUNCT
dpc-2702	8	1	funding	funding	NOUN
dpc-2702	8	2	:	:	PUNCT
dpc-2702	8	3	none	none	NOUN
dpc-2702	8	4	.	.	PUNCT
dpc-2702	9	1	competing	compete	VERB
dpc-2702	9	2	interests	interest	NOUN
dpc-2702	9	3	:	:	PUNCT
dpc-2702	9	4	antonio	antonio	PROPN
dpc-2702	9	5	costanzo	costanzo	PROPN
dpc-2702	9	6	has	have	AUX
dpc-2702	9	7	been	be	AUX
dpc-2702	9	8	a	a	DET
dpc-2702	9	9	consultant	consultant	NOUN
dpc-2702	9	10	and/or	and/or	CCONJ
dpc-2702	9	11	speaker	speaker	NOUN
dpc-2702	9	12	for	for	ADP
dpc-2702	9	13	abb	abb	PROPN
dpc-2702	9	14	-	-	PUNCT
dpc-2702	9	15	vie	vie	PROPN
dpc-2702	9	16	,	,	PUNCT
dpc-2702	9	17	almirall	almirall	ADJ
dpc-2702	9	18	,	,	PUNCT
dpc-2702	9	19	amgen	amgen	PROPN
dpc-2702	9	20	,	,	PUNCT
dpc-2702	9	21	janssen	janssen	PROPN
dpc-2702	9	22	,	,	PUNCT
dpc-2702	9	23	leo	leo	PROPN
dpc-2702	9	24	pharma	pharma	PROPN
dpc-2702	9	25	,	,	PUNCT
dpc-2702	9	26	eli	eli	PROPN
dpc-2702	9	27	lilly	lilly	PROPN
dpc-2702	9	28	,	,	PUNCT
dpc-2702	9	29	galderma	galderma	PROPN
dpc-2702	9	30	,	,	PUNCT
dpc-2702	9	31	boehringer	boehringer	NOUN
dpc-2702	9	32	,	,	PUNCT
dpc-2702	9	33	novartis	novartis	NOUN
dpc-2702	9	34	,	,	PUNCT
dpc-2702	9	35	pfizer	pfizer	NOUN
dpc-2702	9	36	,	,	PUNCT
dpc-2702	9	37	sandoz	sandoz	PROPN
dpc-2702	9	38	,	,	PUNCT
dpc-2702	9	39	and	and	CCONJ
dpc-2702	9	40	ucb	ucb	PROPN
dpc-2702	9	41	.	.	PUNCT
dpc-2702	10	1	alessandra	alessandra	PROPN
dpc-2702	10	2	narcisi	narcisi	PROPN
dpc-2702	10	3	has	have	AUX
dpc-2702	10	4	been	be	AUX
dpc-2702	10	5	a	a	DET
dpc-2702	10	6	consultant	consultant	NOUN
dpc-2702	10	7	and/or	and/or	CCONJ
dpc-2702	10	8	speaker	speaker	NOUN
dpc-2702	10	9	for	for	ADP
dpc-2702	10	10	abb	abb	PROPN
dpc-2702	10	11	-	-	PUNCT
dpc-2702	10	12	vie	vie	PROPN
dpc-2702	10	13	,	,	PUNCT
dpc-2702	10	14	almirall	almirall	ADJ
dpc-2702	10	15	,	,	PUNCT
dpc-2702	10	16	amgen	amgen	PROPN
dpc-2702	10	17	,	,	PUNCT
dpc-2702	10	18	janssen	janssen	PROPN
dpc-2702	10	19	,	,	PUNCT
dpc-2702	10	20	leo	leo	PROPN
dpc-2702	10	21	pharma	pharma	PROPN
dpc-2702	10	22	,	,	PUNCT
dpc-2702	10	23	eli	eli	PROPN
dpc-2702	10	24	lilly	lilly	PROPN
dpc-2702	10	25	,	,	PUNCT
dpc-2702	10	26	boehringer	boehringer	PROPN
dpc-2702	10	27	,	,	PUNCT
dpc-2702	10	28	novartis	novartis	NOUN
dpc-2702	10	29	,	,	PUNCT
dpc-2702	10	30	pfizer	pfizer	NOUN
dpc-2702	10	31	and	and	CCONJ
dpc-2702	10	32	ucb	ucb	PROPN
dpc-2702	10	33	.	.	PROPN
dpc-2702	11	1	luigi	luigi	PROPN
dpc-2702	11	2	gargiulo	gargiulo	PROPN
dpc-2702	11	3	,	,	PUNCT
dpc-2702	11	4	carlo	carlo	PROPN
dpc-2702	11	5	alberto	alberto	PROPN
dpc-2702	11	6	vignoli	vignoli	PROPN
dpc-2702	11	7	,	,	PUNCT
dpc-2702	11	8	giulia	giulia	PROPN
dpc-2702	11	9	pavia	pavia	PROPN
dpc-2702	11	10	and	and	CCONJ
dpc-2702	11	11	chiara	chiara	PROPN
dpc-2702	11	12	perugini	perugini	NOUN
dpc-2702	11	13	have	have	VERB
dpc-2702	11	14	nothing	nothing	PRON
dpc-2702	11	15	to	to	PART
dpc-2702	11	16	disclose	disclose	VERB
dpc-2702	11	17	.	.	PUNCT
dpc-2702	12	1	authorship	authorship	NOUN
dpc-2702	12	2	:	:	PUNCT
dpc-2702	12	3	all	all	DET
dpc-2702	12	4	authors	author	NOUN
dpc-2702	12	5	have	have	AUX
dpc-2702	12	6	contributed	contribute	VERB
dpc-2702	12	7	significantly	significantly	ADV
dpc-2702	12	8	to	to	ADP
dpc-2702	12	9	this	this	DET
dpc-2702	12	10	publication	publication	NOUN
dpc-2702	12	11	.	.	PUNCT
dpc-2702	13	1	corresponding	correspond	VERB
dpc-2702	13	2	author	author	NOUN
dpc-2702	13	3	:	:	PUNCT
dpc-2702	13	4	dr	dr	PROPN
dpc-2702	13	5	.	.	PROPN
dpc-2702	13	6	carlo	carlo	PROPN
dpc-2702	13	7	alberto	alberto	PROPN
dpc-2702	13	8	vignoli	vignoli	PROPN
dpc-2702	13	9	,	,	PUNCT
dpc-2702	13	10	md	md	PROPN
dpc-2702	13	11	,	,	PUNCT
dpc-2702	13	12	dermatology	dermatology	NOUN
dpc-2702	13	13	unit	unit	NOUN
dpc-2702	13	14	,	,	PUNCT
dpc-2702	13	15	department	department	NOUN
dpc-2702	13	16	of	of	ADP
dpc-2702	13	17	biomedical	biomedical	ADJ
dpc-2702	13	18	sciences	science	NOUN
dpc-2702	13	19	,	,	PUNCT
dpc-2702	13	20	irccs	ircc	VERB
dpc-2702	13	21	humanitas	humanitas	NOUN
dpc-2702	13	22	research	research	NOUN
dpc-2702	13	23	hospital	hospital	NOUN
dpc-2702	13	24	,	,	PUNCT
dpc-2702	13	25	humanitas	humanitas	X
dpc-2702	13	26	university	university	NOUN
dpc-2702	13	27	,	,	PUNCT
dpc-2702	13	28	rozzano	rozzano	PROPN
dpc-2702	13	29	(	(	PUNCT
dpc-2702	13	30	mi	mi	PROPN
dpc-2702	13	31	)	)	PUNCT
dpc-2702	13	32	,	,	PUNCT
dpc-2702	13	33	itlay	itlay	NOUN
dpc-2702	13	34	.	.	PUNCT
dpc-2702	14	1	tel	tel	ADP
dpc-2702	14	2	:	:	PUNCT
dpc-2702	14	3	+39	+39	PROPN
dpc-2702	14	4	0282244050	0282244050	NUM
dpc-2702	14	5	email	email	NOUN
dpc-2702	14	6	:	:	PUNCT
dpc-2702	14	7	c.alberto.vignoli@gmail.com	c.alberto.vignoli@gmail.com	X
dpc-2702	15	1	introduction	introduction	NOUN
dpc-2702	15	2	palmoplantar	palmoplantar	NOUN
dpc-2702	15	3	pustular	pustular	ADJ
dpc-2702	15	4	psoriasis	psoriasis	NOUN
dpc-2702	15	5	(	(	PUNCT
dpc-2702	15	6	pppp	pppp	PROPN
dpc-2702	15	7	)	)	PUNCT
dpc-2702	15	8	,	,	PUNCT
dpc-2702	15	9	according	accord	VERB
dpc-2702	15	10	to	to	ADP
dpc-2702	15	11	the	the	DET
dpc-2702	15	12	eraspen	eraspen	NOUN
dpc-2702	15	13	(	(	PUNCT
dpc-2702	15	14	european	european	ADJ
dpc-2702	15	15	rare	rare	ADJ
dpc-2702	15	16	and	and	CCONJ
dpc-2702	15	17	severe	severe	ADJ
dpc-2702	15	18	psoriasis	psoriasis	NOUN
dpc-2702	15	19	expert	expert	NOUN
dpc-2702	15	20	network	network	NOUN
dpc-2702	15	21	)	)	PUNCT
dpc-2702	15	22	guidelines	guideline	NOUN
dpc-2702	15	23	,	,	PUNCT
dpc-2702	15	24	is	be	AUX
dpc-2702	15	25	defined	define	VERB
dpc-2702	15	26	as	as	ADP
dpc-2702	15	27	primary	primary	ADJ
dpc-2702	15	28	,	,	PUNCT
dpc-2702	15	29	persistent	persistent	ADJ
dpc-2702	15	30	(	(	PUNCT
dpc-2702	15	31	>	>	SYM
dpc-2702	15	32	3	3	NUM
dpc-2702	15	33	months	month	NOUN
dpc-2702	15	34	)	)	PUNCT
dpc-2702	15	35	,	,	PUNCT
dpc-2702	15	36	sterile	sterile	ADJ
dpc-2702	15	37	,	,	PUNCT
dpc-2702	15	38	macroscopically	macroscopically	ADV
dpc-2702	15	39	visible	visible	ADJ
dpc-2702	15	40	pustular	pustular	ADJ
dpc-2702	15	41	eruption	eruption	NOUN
dpc-2702	15	42	on	on	ADP
dpc-2702	15	43	palms	palm	NOUN
dpc-2702	15	44	and/or	and/or	CCONJ
dpc-2702	15	45	soles	sole	VERB
dpc-2702	15	46	[	[	X
dpc-2702	15	47	1,2	1,2	NUM
dpc-2702	15	48	]	]	PUNCT
dpc-2702	15	49	.	.	PUNCT
dpc-2702	16	1	it	it	PRON
dpc-2702	16	2	can	can	AUX
dpc-2702	16	3	present	present	VERB
dpc-2702	16	4	with	with	ADP
dpc-2702	16	5	or	or	CCONJ
dpc-2702	16	6	without	without	ADP
dpc-2702	16	7	concomitant	concomitant	ADJ
dpc-2702	16	8	plaque	plaque	NOUN
dpc-2702	16	9	psoriasis	psoriasis	NOUN
dpc-2702	16	10	[	[	X
dpc-2702	16	11	2	2	NUM
dpc-2702	16	12	]	]	PUNCT
dpc-2702	16	13	.	.	PUNCT
dpc-2702	17	1	the	the	DET
dpc-2702	17	2	pathophysiology	pathophysiology	NOUN
dpc-2702	17	3	of	of	ADP
dpc-2702	17	4	this	this	DET
dpc-2702	17	5	condition	condition	NOUN
dpc-2702	17	6	is	be	AUX
dpc-2702	17	7	not	not	PART
dpc-2702	17	8	fully	fully	ADV
dpc-2702	17	9	understood	understand	VERB
dpc-2702	17	10	,	,	PUNCT
dpc-2702	17	11	both	both	CCONJ
dpc-2702	17	12	the	the	DET
dpc-2702	17	13	innate	innate	ADJ
dpc-2702	17	14	and	and	CCONJ
dpc-2702	17	15	adaptive	adaptive	ADJ
dpc-2702	17	16	immune	immune	ADJ
dpc-2702	17	17	systems	system	NOUN
dpc-2702	17	18	are	be	AUX
dpc-2702	17	19	involved	involve	VERB
dpc-2702	17	20	[	[	PUNCT
dpc-2702	17	21	2	2	NUM
dpc-2702	17	22	]	]	PUNCT
dpc-2702	17	23	.	.	PUNCT
dpc-2702	18	1	a	a	DET
dpc-2702	18	2	primary	primary	ADJ
dpc-2702	18	3	role	role	NOUN
dpc-2702	18	4	is	be	AUX
dpc-2702	18	5	played	play	VERB
dpc-2702	18	6	by	by	ADP
dpc-2702	18	7	the	the	DET
dpc-2702	18	8	increased	increase	VERB
dpc-2702	18	9	expression	expression	NOUN
dpc-2702	18	10	of	of	ADP
dpc-2702	18	11	interleukin-8	interleukin-8	NUM
dpc-2702	18	12	(	(	PUNCT
dpc-2702	18	13	il-8	il-8	NOUN
dpc-2702	18	14	)	)	PUNCT
dpc-2702	18	15	and	and	CCONJ
dpc-2702	18	16	by	by	ADP
dpc-2702	18	17	il-17	il-17	ADV
dpc-2702	18	18	related	related	ADJ
dpc-2702	18	19	cytokines	cytokine	NOUN
dpc-2702	18	20	(	(	PUNCT
dpc-2702	18	21	including	include	VERB
dpc-2702	18	22	l-17a	l-17a	PROPN
dpc-2702	18	23	/	/	SYM
dpc-2702	18	24	f	f	PROPN
dpc-2702	18	25	,	,	PUNCT
dpc-2702	18	26	il-23a	il-23a	NOUN
dpc-2702	18	27	,	,	PUNCT
dpc-2702	18	28	il-23	il-23	NOUN
dpc-2702	18	29	receptor	receptor	NOUN
dpc-2702	18	30	)	)	PUNCT
dpc-2702	18	31	.	.	PUNCT
dpc-2702	19	1	a	a	DET
dpc-2702	19	2	 	 	SPACE
dpc-2702	19	3	role	role	NOUN
dpc-2702	19	4	has	have	AUX
dpc-2702	19	5	been	be	AUX
dpc-2702	19	6	proposed	propose	VERB
dpc-2702	19	7	also	also	ADV
dpc-2702	19	8	for	for	ADP
dpc-2702	19	9	the	the	DET
dpc-2702	19	10	antimicrobial	antimicrobial	ADJ
dpc-2702	19	11	peptide	peptide	NOUN
dpc-2702	19	12	ll-37	ll-37	NOUN
dpc-2702	19	13	,	,	PUNCT
dpc-2702	19	14	which	which	PRON
dpc-2702	19	15	may	may	AUX
dpc-2702	19	16	contribute	contribute	VERB
dpc-2702	19	17	to	to	ADP
dpc-2702	19	18	neutrophil	neutrophil	ADJ
dpc-2702	19	19	recruitment	recruitment	NOUN
dpc-2702	19	20	by	by	ADP
dpc-2702	19	21	upregulating	upregulating	ADJ
dpc-2702	19	22	il-8	il-8	NOUN
dpc-2702	19	23	,	,	PUNCT
dpc-2702	19	24	il-23	il-23	NOUN
dpc-2702	19	25	,	,	PUNCT
dpc-2702	19	26	il-17c	il-17c	NOUN
dpc-2702	19	27	,	,	PUNCT
dpc-2702	19	28	il-1	il-1	PUNCT
dpc-2702	20	1	[	[	X
dpc-2702	20	2	2	2	NUM
dpc-2702	20	3	]	]	PUNCT
dpc-2702	20	4	.	.	PUNCT
dpc-2702	21	1	only	only	ADV
dpc-2702	21	2	limited	limited	ADJ
dpc-2702	21	3	data	datum	NOUN
dpc-2702	21	4	are	be	AUX
dpc-2702	21	5	available	available	ADJ
dpc-2702	21	6	regarding	regard	VERB
dpc-2702	21	7	the	the	DET
dpc-2702	21	8	treatment	treatment	NOUN
dpc-2702	21	9	of	of	ADP
dpc-2702	21	10	pppp	pppp	PROPN
dpc-2702	21	11	with	with	ADP
dpc-2702	21	12	biologics	biologic	NOUN
dpc-2702	21	13	and	and	CCONJ
dpc-2702	21	14	no	no	DET
dpc-2702	21	15	standardized	standardized	ADJ
dpc-2702	21	16	guidelines	guideline	NOUN
dpc-2702	21	17	have	have	AUX
dpc-2702	21	18	been	be	AUX
dpc-2702	21	19	published	publish	VERB
dpc-2702	21	20	yet	yet	ADV
dpc-2702	21	21	[	[	X
dpc-2702	21	22	3	3	NUM
dpc-2702	21	23	]	]	PUNCT
dpc-2702	21	24	.	.	PUNCT
dpc-2702	22	1	case	case	NOUN
dpc-2702	22	2	presentation	presentation	NOUN
dpc-2702	22	3	we	we	PRON
dpc-2702	22	4	present	present	VERB
dpc-2702	22	5	2	2	NUM
dpc-2702	22	6	patients	patient	NOUN
dpc-2702	22	7	with	with	ADP
dpc-2702	22	8	pppp	pppp	PROPN
dpc-2702	22	9	who	who	PRON
dpc-2702	22	10	were	be	AUX
dpc-2702	22	11	successfully	successfully	ADV
dpc-2702	22	12	treated	treat	VERB
dpc-2702	22	13	with	with	ADP
dpc-2702	22	14	risankizumab	risankizumab	NOUN
dpc-2702	22	15	,	,	PUNCT
dpc-2702	22	16	an	an	DET
dpc-2702	22	17	anti	anti	ADJ
dpc-2702	22	18	-	-	ADJ
dpc-2702	22	19	il-23	il-23	ADJ
dpc-2702	22	20	monoclonal	monoclonal	NOUN
dpc-2702	22	21	antibody	antibody	NOUN
dpc-2702	22	22	.	.	PUNCT
dpc-2702	23	1	the	the	DET
dpc-2702	23	2	first	first	ADJ
dpc-2702	23	3	patient	patient	NOUN
dpc-2702	23	4	is	be	AUX
dpc-2702	23	5	a	a	DET
dpc-2702	23	6	32	32	NUM
dpc-2702	23	7	-	-	PUNCT
dpc-2702	23	8	year	year	NOUN
dpc-2702	23	9	-	-	PUNCT
dpc-2702	23	10	old	old	ADJ
dpc-2702	23	11	woman	woman	NOUN
dpc-2702	23	12	,	,	PUNCT
dpc-2702	23	13	affected	affect	VERB
dpc-2702	23	14	by	by	ADP
dpc-2702	23	15	pppp	pppp	PROPN
dpc-2702	23	16	and	and	CCONJ
dpc-2702	23	17	plaque	plaque	NOUN
dpc-2702	23	18	psoriasis	psoriasis	NOUN
dpc-2702	23	19	since	since	SCONJ
dpc-2702	23	20	2020	2020	NUM
dpc-2702	23	21	.	.	PUNCT
dpc-2702	24	1	on	on	ADP
dpc-2702	24	2	clinical	clinical	ADJ
dpc-2702	24	3	examination	examination	NOUN
dpc-2702	24	4	,	,	PUNCT
dpc-2702	24	5	we	we	PRON
dpc-2702	24	6	observed	observe	VERB
dpc-2702	24	7	pustular	pustular	ADJ
dpc-2702	24	8	lesions	lesion	NOUN
dpc-2702	24	9	on	on	ADP
dpc-2702	24	10	the	the	DET
dpc-2702	24	11	palms	palm	NOUN
dpc-2702	24	12	and	and	CCONJ
dpc-2702	24	13	soles	sol	NOUN
dpc-2702	24	14	(	(	PUNCT
dpc-2702	24	15	figure	figure	NOUN
dpc-2702	24	16	1	1	NUM
dpc-2702	24	17	)	)	PUNCT
dpc-2702	24	18	along	along	ADP
dpc-2702	24	19	with	with	ADP
dpc-2702	24	20	erythematous	erythematous	ADJ
dpc-2702	24	21	and	and	CCONJ
dpc-2702	24	22	scaly	scaly	ADJ
dpc-2702	24	23	plaques	plaque	NOUN
dpc-2702	24	24	on	on	ADP
dpc-2702	24	25	the	the	DET
dpc-2702	24	26	scalp	scalp	NOUN
dpc-2702	24	27	.	.	PUNCT
dpc-2702	25	1	palmoplantar	palmoplantar	NOUN
dpc-2702	25	2	investigator	investigator	NOUN
dpc-2702	25	3	global	global	ADJ
dpc-2702	25	4	assessment	assessment	NOUN
dpc-2702	25	5	(	(	PUNCT
dpc-2702	25	6	ppiga	ppiga	ADJ
dpc-2702	25	7	)	)	PUNCT
dpc-2702	25	8	score	score	NOUN
dpc-2702	25	9	was	be	AUX
dpc-2702	25	10	3	3	NUM
dpc-2702	25	11	on	on	ADP
dpc-2702	25	12	a	a	DET
dpc-2702	25	13	5	5	NUM
dpc-2702	25	14	-	-	PUNCT
dpc-2702	25	15	point	point	NOUN
dpc-2702	25	16	scale	scale	NOUN
dpc-2702	25	17	.	.	PUNCT
dpc-2702	26	1	psoriasis	psoriasis	NOUN
dpc-2702	26	2	area	area	NOUN
dpc-2702	26	3	severity	severity	NOUN
dpc-2702	26	4	index	index	NOUN
dpc-2702	26	5	(	(	PUNCT
dpc-2702	26	6	pasi	pasi	NOUN
dpc-2702	26	7	)	)	PUNCT
dpc-2702	26	8	was	be	AUX
dpc-2702	26	9	5.2	5.2	NUM
dpc-2702	26	10	.	.	PUNCT
dpc-2702	27	1	as	as	SCONJ
dpc-2702	27	2	topical	topical	ADJ
dpc-2702	27	3	corticosteroids	corticosteroid	NOUN
dpc-2702	27	4	had	have	AUX
dpc-2702	27	5	previously	previously	ADV
dpc-2702	27	6	been	be	AUX
dpc-2702	27	7	ineffective	ineffective	ADJ
dpc-2702	27	8	,	,	PUNCT
dpc-2702	27	9	given	give	VERB
dpc-2702	27	10	the	the	DET
dpc-2702	27	11	age	age	NOUN
dpc-2702	27	12	of	of	ADP
dpc-2702	27	13	the	the	DET
dpc-2702	27	14	patient	patient	NOUN
dpc-2702	27	15	,	,	PUNCT
dpc-2702	27	16	acitretin	acitretin	NOUN
dpc-2702	27	17	was	be	AUX
dpc-2702	27	18	not	not	PART
dpc-2702	27	19	recommended	recommend	VERB
dpc-2702	27	20	.	.	PUNCT
dpc-2702	28	1	because	because	SCONJ
dpc-2702	28	2	of	of	ADP
dpc-2702	28	3	the	the	DET
dpc-2702	28	4	impact	impact	NOUN
dpc-2702	28	5	of	of	ADP
dpc-2702	28	6	the	the	DET
dpc-2702	28	7	disease	disease	NOUN
dpc-2702	28	8	on	on	ADP
dpc-2702	28	9	her	her	PRON
dpc-2702	28	10	quality	quality	NOUN
dpc-2702	28	11	of	of	ADP
dpc-2702	28	12	life	life	NOUN
dpc-2702	28	13	(	(	PUNCT
dpc-2702	28	14	dermatology	dermatology	NOUN
dpc-2702	28	15	life	life	NOUN
dpc-2702	28	16	quality	quality	NOUN
dpc-2702	28	17	index	index	NOUN
dpc-2702	28	18	[	[	X
dpc-2702	28	19	dlqi	dlqi	X
dpc-2702	28	20	]	]	PUNCT
dpc-2702	28	21	was	be	AUX
dpc-2702	28	22	12	12	NUM
dpc-2702	28	23	)	)	PUNCT
dpc-2702	28	24	,	,	PUNCT
dpc-2702	28	25	we	we	PRON
dpc-2702	28	26	prescribed	prescribe	VERB
dpc-2702	28	27	risankizumab	risankizumab	NOUN
dpc-2702	28	28	75	75	NUM
dpc-2702	28	29	mg	mg	PROPN
dpc-2702	28	30	,	,	PUNCT
dpc-2702	28	31	two	two	NUM
dpc-2702	28	32	subcutaneous	subcutaneous	ADJ
dpc-2702	28	33	injections	injection	NOUN
dpc-2702	28	34	at	at	ADP
dpc-2702	28	35	weeks	week	NOUN
dpc-2702	28	36	0	0	NUM
dpc-2702	28	37	,	,	PUNCT
dpc-2702	28	38	4	4	NUM
dpc-2702	28	39	,	,	PUNCT
dpc-2702	28	40	and	and	CCONJ
dpc-2702	28	41	then	then	ADV
dpc-2702	28	42	every	every	DET
dpc-2702	28	43	12	12	NUM
dpc-2702	28	44	weeks	week	NOUN
dpc-2702	28	45	.	.	PUNCT
dpc-2702	29	1	after	after	ADP
dpc-2702	29	2	16	16	NUM
dpc-2702	29	3	weeks	week	NOUN
dpc-2702	29	4	the	the	DET
dpc-2702	29	5	patient	patient	NOUN
dpc-2702	29	6	returned	return	VERB
dpc-2702	29	7	showing	show	VERB
dpc-2702	29	8	only	only	ADV
dpc-2702	29	9	a	a	DET
dpc-2702	29	10	slight	slight	ADJ
dpc-2702	29	11	improvement	improvement	NOUN
dpc-2702	29	12	,	,	PUNCT
dpc-2702	29	13	but	but	CCONJ
dpc-2702	29	14	at	at	ADP
dpc-2702	29	15	week	week	NOUN
dpc-2702	29	16	28	28	NUM
dpc-2702	29	17	we	we	PRON
dpc-2702	29	18	observed	observe	VERB
dpc-2702	29	19	complete	complete	ADJ
dpc-2702	29	20	skin	skin	NOUN
dpc-2702	29	21	2	2	NUM
dpc-2702	29	22	research	research	NOUN
dpc-2702	29	23	letter	letter	NOUN
dpc-2702	30	1	|	|	ADV
dpc-2702	30	2	dermatol	dermatol	ADJ
dpc-2702	30	3	pract	pract	NOUN
dpc-2702	30	4	concept	concept	NOUN
dpc-2702	30	5	.	.	PUNCT
dpc-2702	31	1	2023;13(2):e2023097	2023;13(2):e2023097	NUM
dpc-2702	31	2	clearance	clearance	NOUN
dpc-2702	31	3	,	,	PUNCT
dpc-2702	31	4	with	with	ADP
dpc-2702	31	5	a	a	DET
dpc-2702	31	6	ppiga	ppiga	NOUN
dpc-2702	31	7	of	of	ADP
dpc-2702	31	8	0	0	NUM
dpc-2702	31	9	(	(	PUNCT
dpc-2702	31	10	figure	figure	NOUN
dpc-2702	31	11	2	2	NUM
dpc-2702	31	12	)	)	PUNCT
dpc-2702	31	13	.	.	PUNCT
dpc-2702	32	1	the	the	DET
dpc-2702	32	2	patient	patient	NOUN
dpc-2702	32	3	to	to	ADP
dpc-2702	32	4	date	date	NOUN
dpc-2702	32	5	has	have	AUX
dpc-2702	32	6	completed	complete	VERB
dpc-2702	32	7	a	a	DET
dpc-2702	32	8	year	year	NOUN
dpc-2702	32	9	of	of	ADP
dpc-2702	32	10	therapy	therapy	NOUN
dpc-2702	32	11	and	and	CCONJ
dpc-2702	32	12	she	she	PRON
dpc-2702	32	13	has	have	AUX
dpc-2702	32	14	maintained	maintain	VERB
dpc-2702	32	15	the	the	DET
dpc-2702	32	16	remission	remission	NOUN
dpc-2702	32	17	.	.	PUNCT
dpc-2702	33	1	the	the	DET
dpc-2702	33	2	second	second	ADJ
dpc-2702	33	3	patient	patient	NOUN
dpc-2702	33	4	is	be	AUX
dpc-2702	33	5	a	a	DET
dpc-2702	33	6	47	47	NUM
dpc-2702	33	7	-	-	PUNCT
dpc-2702	33	8	year	year	NOUN
dpc-2702	33	9	-	-	PUNCT
dpc-2702	33	10	old	old	ADJ
dpc-2702	33	11	woman	woman	NOUN
dpc-2702	33	12	,	,	PUNCT
dpc-2702	33	13	affected	affect	VERB
dpc-2702	33	14	from	from	ADP
dpc-2702	33	15	pppp	pppp	PROPN
dpc-2702	33	16	since	since	SCONJ
dpc-2702	33	17	2018	2018	NUM
dpc-2702	33	18	,	,	PUNCT
dpc-2702	33	19	previously	previously	ADV
dpc-2702	33	20	unsuccessfully	unsuccessfully	ADV
dpc-2702	33	21	treated	treat	VERB
dpc-2702	33	22	with	with	ADP
dpc-2702	33	23	acitretin	acitretin	NOUN
dpc-2702	33	24	.	.	PUNCT
dpc-2702	34	1	she	she	PRON
dpc-2702	34	2	had	have	VERB
dpc-2702	34	3	a	a	DET
dpc-2702	34	4	history	history	NOUN
dpc-2702	34	5	of	of	ADP
dpc-2702	34	6	hepatitis	hepatitis	PROPN
dpc-2702	34	7	b	b	PROPN
dpc-2702	34	8	with	with	ADP
dpc-2702	34	9	positive	positive	ADJ
dpc-2702	34	10	anti	anti	ADJ
dpc-2702	34	11	-	-	ADJ
dpc-2702	34	12	hbc	hbc	ADJ
dpc-2702	34	13	and	and	CCONJ
dpc-2702	34	14	anti	anti	ADJ
dpc-2702	34	15	-	-	ADJ
dpc-2702	34	16	hbs	hbs	ADJ
dpc-2702	34	17	.	.	PUNCT
dpc-2702	35	1	on	on	ADP
dpc-2702	35	2	physical	physical	ADJ
dpc-2702	35	3	examination	examination	NOUN
dpc-2702	35	4	we	we	PRON
dpc-2702	35	5	observed	observe	VERB
dpc-2702	35	6	erythematous	erythematous	ADJ
dpc-2702	35	7	,	,	PUNCT
dpc-2702	35	8	scaly	scaly	NOUN
dpc-2702	35	9	patches	patch	NOUN
dpc-2702	35	10	on	on	ADP
dpc-2702	35	11	the	the	DET
dpc-2702	35	12	palms	palm	NOUN
dpc-2702	35	13	and	and	CCONJ
dpc-2702	35	14	palmoplantar	palmoplantar	NOUN
dpc-2702	35	15	pustules	pustule	NOUN
dpc-2702	35	16	(	(	PUNCT
dpc-2702	35	17	ppiga=3	ppiga=3	PROPN
dpc-2702	35	18	,	,	PUNCT
dpc-2702	35	19	pasi=11.3	pasi=11.3	NOUN
dpc-2702	35	20	)	)	PUNCT
dpc-2702	35	21	.	.	PUNCT
dpc-2702	36	1	given	give	VERB
dpc-2702	36	2	her	her	PRON
dpc-2702	36	3	comorbidities	comorbiditie	NOUN
dpc-2702	36	4	and	and	CCONJ
dpc-2702	36	5	the	the	DET
dpc-2702	36	6	concomitant	concomitant	ADJ
dpc-2702	36	7	presence	presence	NOUN
dpc-2702	36	8	of	of	ADP
dpc-2702	36	9	plaque	plaque	NOUN
dpc-2702	36	10	psoriasis	psoriasis	NOUN
dpc-2702	36	11	,	,	PUNCT
dpc-2702	36	12	with	with	ADP
dpc-2702	36	13	the	the	DET
dpc-2702	36	14	consensus	consensus	NOUN
dpc-2702	36	15	of	of	ADP
dpc-2702	36	16	the	the	DET
dpc-2702	36	17	hepatologist	hepatologist	NOUN
dpc-2702	36	18	,	,	PUNCT
dpc-2702	36	19	we	we	PRON
dpc-2702	36	20	started	start	VERB
dpc-2702	36	21	risankizumab	risankizumab	NOUN
dpc-2702	36	22	.	.	PUNCT
dpc-2702	37	1	at	at	ADP
dpc-2702	37	2	week	week	NOUN
dpc-2702	37	3	16	16	NUM
dpc-2702	37	4	she	she	PRON
dpc-2702	37	5	achieved	achieve	VERB
dpc-2702	37	6	complete	complete	ADJ
dpc-2702	37	7	skin	skin	NOUN
dpc-2702	37	8	clearance	clearance	NOUN
dpc-2702	37	9	and	and	CCONJ
dpc-2702	37	10	she	she	PRON
dpc-2702	37	11	has	have	AUX
dpc-2702	37	12	maintained	maintain	VERB
dpc-2702	37	13	the	the	DET
dpc-2702	37	14	remission	remission	NOUN
dpc-2702	37	15	after	after	ADP
dpc-2702	37	16	two	two	NUM
dpc-2702	37	17	years	year	NOUN
dpc-2702	37	18	(	(	PUNCT
dpc-2702	37	19	ppiga=3	ppiga=3	PROPN
dpc-2702	37	20	)	)	PUNCT
dpc-2702	37	21	.	.	PUNCT
dpc-2702	38	1	both	both	DET
dpc-2702	38	2	patients	patient	NOUN
dpc-2702	38	3	had	have	AUX
dpc-2702	38	4	provided	provide	VERB
dpc-2702	38	5	written	write	VERB
dpc-2702	38	6	consent	consent	NOUN
dpc-2702	38	7	for	for	ADP
dpc-2702	38	8	retrospective	retrospective	ADJ
dpc-2702	38	9	study	study	NOUN
dpc-2702	38	10	of	of	ADP
dpc-2702	38	11	data	datum	NOUN
dpc-2702	38	12	collected	collect	VERB
dpc-2702	38	13	during	during	ADP
dpc-2702	38	14	routine	routine	ADJ
dpc-2702	38	15	clinical	clinical	ADJ
dpc-2702	38	16	practice	practice	NOUN
dpc-2702	38	17	(	(	PUNCT
dpc-2702	38	18	demographics	demographic	NOUN
dpc-2702	38	19	,	,	PUNCT
dpc-2702	38	20	clinical	clinical	ADJ
dpc-2702	38	21	scores	score	NOUN
dpc-2702	38	22	)	)	PUNCT
dpc-2702	38	23	.	.	PUNCT
dpc-2702	39	1	conclusions	conclusion	NOUN
dpc-2702	39	2	in	in	ADP
dpc-2702	39	3	scientific	scientific	ADJ
dpc-2702	39	4	literature	literature	NOUN
dpc-2702	39	5	there	there	PRON
dpc-2702	39	6	is	be	VERB
dpc-2702	39	7	paucity	paucity	NOUN
dpc-2702	39	8	of	of	ADP
dpc-2702	39	9	data	datum	NOUN
dpc-2702	39	10	regarding	regard	VERB
dpc-2702	39	11	the	the	DET
dpc-2702	39	12	efficacy	efficacy	NOUN
dpc-2702	39	13	of	of	ADP
dpc-2702	39	14	biologics	biologic	NOUN
dpc-2702	39	15	in	in	ADP
dpc-2702	39	16	pustular	pustular	ADJ
dpc-2702	39	17	psoriasis	psoriasis	NOUN
dpc-2702	39	18	,	,	PUNCT
dpc-2702	39	19	especially	especially	ADV
dpc-2702	39	20	for	for	ADP
dpc-2702	39	21	palmoplantar	palmoplantar	NOUN
dpc-2702	39	22	subtype	subtype	NOUN
dpc-2702	39	23	.	.	PUNCT
dpc-2702	40	1	a	a	DET
dpc-2702	40	2	few	few	ADJ
dpc-2702	40	3	data	datum	NOUN
dpc-2702	40	4	from	from	ADP
dpc-2702	40	5	real	real	ADJ
dpc-2702	40	6	-	-	PUNCT
dpc-2702	40	7	life	life	NOUN
dpc-2702	40	8	experiences	experience	NOUN
dpc-2702	40	9	and	and	CCONJ
dpc-2702	40	10	case	case	NOUN
dpc-2702	40	11	reports	report	NOUN
dpc-2702	40	12	are	be	AUX
dpc-2702	40	13	available	available	ADJ
dpc-2702	40	14	for	for	ADP
dpc-2702	40	15	guselkumab	guselkumab	NOUN
dpc-2702	40	16	,	,	PUNCT
dpc-2702	40	17	secukinumab	secukinumab	NOUN
dpc-2702	40	18	and	and	CCONJ
dpc-2702	40	19	apremilast	apremilast	PROPN
dpc-2702	40	20	,	,	PUNCT
dpc-2702	40	21	which	which	PRON
dpc-2702	40	22	have	have	AUX
dpc-2702	40	23	demonstrated	demonstrate	VERB
dpc-2702	40	24	a	a	DET
dpc-2702	40	25	moderate	moderate	ADJ
dpc-2702	40	26	efficacy	efficacy	NOUN
dpc-2702	40	27	[	[	X
dpc-2702	40	28	4	4	NUM
dpc-2702	40	29	]	]	PUNCT
dpc-2702	40	30	.	.	PUNCT
dpc-2702	41	1	we	we	PRON
dpc-2702	41	2	decided	decide	VERB
dpc-2702	41	3	to	to	PART
dpc-2702	41	4	prescribe	prescribe	VERB
dpc-2702	41	5	risankizumab	risankizumab	NOUN
dpc-2702	41	6	for	for	ADP
dpc-2702	41	7	multiple	multiple	ADJ
dpc-2702	41	8	reasons	reason	NOUN
dpc-2702	41	9	:	:	PUNCT
dpc-2702	41	10	our	our	PRON
dpc-2702	41	11	favorable	favorable	ADJ
dpc-2702	41	12	experience	experience	NOUN
dpc-2702	41	13	with	with	ADP
dpc-2702	41	14	this	this	DET
dpc-2702	41	15	drug	drug	NOUN
dpc-2702	41	16	,	,	PUNCT
dpc-2702	41	17	including	include	VERB
dpc-2702	41	18	a	a	DET
dpc-2702	41	19	patient	patient	NOUN
dpc-2702	41	20	with	with	ADP
dpc-2702	41	21	a	a	DET
dpc-2702	41	22	flare	flare	NOUN
dpc-2702	41	23	of	of	ADP
dpc-2702	41	24	generalized	generalized	ADJ
dpc-2702	41	25	pustular	pustular	ADJ
dpc-2702	41	26	psoriasis	psoriasis	NOUN
dpc-2702	41	27	[	[	X
dpc-2702	41	28	5	5	NUM
dpc-2702	41	29	]	]	PUNCT
dpc-2702	41	30	;	;	PUNCT
dpc-2702	41	31	the	the	DET
dpc-2702	41	32	high	high	ADJ
dpc-2702	41	33	safety	safety	NOUN
dpc-2702	41	34	profile	profile	NOUN
dpc-2702	41	35	,	,	PUNCT
dpc-2702	41	36	even	even	ADV
dpc-2702	41	37	in	in	ADP
dpc-2702	41	38	patients	patient	NOUN
dpc-2702	41	39	with	with	ADP
dpc-2702	41	40	serological	serological	ADJ
dpc-2702	41	41	evidence	evidence	NOUN
dpc-2702	41	42	of	of	ADP
dpc-2702	41	43	viral	viral	ADJ
dpc-2702	41	44	hepatitis	hepatitis	NOUN
dpc-2702	42	1	[	[	X
dpc-2702	42	2	6	6	NUM
dpc-2702	42	3	]	]	PUNCT
dpc-2702	42	4	;	;	PUNCT
dpc-2702	42	5	the	the	DET
dpc-2702	42	6	high	high	ADJ
dpc-2702	42	7	effectiveness	effectiveness	NOUN
dpc-2702	42	8	on	on	ADP
dpc-2702	42	9	difficult	difficult	ADJ
dpc-2702	42	10	-	-	PUNCT
dpc-2702	42	11	to	to	ADP
dpc-2702	42	12	-	-	PUNCT
dpc-2702	42	13	treat	treat	NOUN
dpc-2702	42	14	areas	area	NOUN
dpc-2702	42	15	[	[	X
dpc-2702	42	16	5	5	NUM
dpc-2702	42	17	]	]	PUNCT
dpc-2702	42	18	.	.	PUNCT
dpc-2702	43	1	in	in	ADP
dpc-2702	43	2	the	the	DET
dpc-2702	43	3	first	first	ADJ
dpc-2702	43	4	patient	patient	NOUN
dpc-2702	43	5	,	,	PUNCT
dpc-2702	43	6	we	we	PRON
dpc-2702	43	7	observed	observe	VERB
dpc-2702	43	8	a	a	DET
dpc-2702	43	9	slower	slow	ADJ
dpc-2702	43	10	response	response	NOUN
dpc-2702	43	11	compared	compare	VERB
dpc-2702	43	12	to	to	ADP
dpc-2702	43	13	our	our	PRON
dpc-2702	43	14	experience	experience	NOUN
dpc-2702	43	15	with	with	ADP
dpc-2702	43	16	risankizumab	risankizumab	NOUN
dpc-2702	43	17	in	in	ADP
dpc-2702	43	18	psoriasis	psoriasis	NOUN
dpc-2702	43	19	vulgaris	vulgaris	NOUN
dpc-2702	43	20	,	,	PUNCT
dpc-2702	43	21	however	however	ADV
dpc-2702	43	22	this	this	PRON
dpc-2702	43	23	is	be	AUX
dpc-2702	43	24	expectable	expectable	ADJ
dpc-2702	43	25	given	give	VERB
dpc-2702	43	26	the	the	DET
dpc-2702	43	27	resistance	resistance	NOUN
dpc-2702	43	28	of	of	ADP
dpc-2702	43	29	these	these	DET
dpc-2702	43	30	areas	area	NOUN
dpc-2702	43	31	to	to	ADP
dpc-2702	43	32	treatment	treatment	NOUN
dpc-2702	43	33	[	[	X
dpc-2702	43	34	5	5	NUM
dpc-2702	43	35	]	]	PUNCT
dpc-2702	43	36	.	.	PUNCT
dpc-2702	44	1	to	to	ADP
dpc-2702	44	2	our	our	PRON
dpc-2702	44	3	knowledge	knowledge	NOUN
dpc-2702	44	4	,	,	PUNCT
dpc-2702	44	5	the	the	DET
dpc-2702	44	6	experience	experience	NOUN
dpc-2702	44	7	on	on	ADP
dpc-2702	44	8	the	the	DET
dpc-2702	44	9	effectiveness	effectiveness	NOUN
dpc-2702	44	10	of	of	ADP
dpc-2702	44	11	risankizumab	risankizumab	NOUN
dpc-2702	44	12	in	in	ADP
dpc-2702	44	13	pppp	pppp	PROPN
dpc-2702	44	14	is	be	AUX
dpc-2702	44	15	limited	limited	ADJ
dpc-2702	44	16	.	.	PUNCT
dpc-2702	45	1	further	further	ADJ
dpc-2702	45	2	data	datum	NOUN
dpc-2702	45	3	,	,	PUNCT
dpc-2702	45	4	corroborated	corroborate	VERB
dpc-2702	45	5	by	by	ADP
dpc-2702	45	6	longitudinal	longitudinal	ADJ
dpc-2702	45	7	studies	study	NOUN
dpc-2702	45	8	with	with	ADP
dpc-2702	45	9	higher	high	ADJ
dpc-2702	45	10	numbers	number	NOUN
dpc-2702	45	11	of	of	ADP
dpc-2702	45	12	patients	patient	NOUN
dpc-2702	45	13	,	,	PUNCT
dpc-2702	45	14	are	be	AUX
dpc-2702	45	15	needed	need	VERB
dpc-2702	45	16	to	to	PART
dpc-2702	45	17	assess	assess	VERB
dpc-2702	45	18	the	the	DET
dpc-2702	45	19	role	role	NOUN
dpc-2702	45	20	of	of	ADP
dpc-2702	45	21	risankizumab	risankizumab	NOUN
dpc-2702	45	22	and	and	CCONJ
dpc-2702	45	23	other	other	ADJ
dpc-2702	45	24	biologic	biologic	NOUN
dpc-2702	45	25	drugs	drug	NOUN
dpc-2702	45	26	for	for	ADP
dpc-2702	45	27	the	the	DET
dpc-2702	45	28	treatment	treatment	NOUN
dpc-2702	45	29	of	of	ADP
dpc-2702	45	30	pppp	pppp	PROPN
dpc-2702	45	31	.	.	PUNCT
dpc-2702	46	1	references	reference	NOUN
dpc-2702	46	2	1	1	NUM
dpc-2702	46	3	.	.	PUNCT
dpc-2702	46	4	navarini	navarini	PROPN
dpc-2702	46	5	aa	aa	NOUN
dpc-2702	46	6	,	,	PUNCT
dpc-2702	46	7	burden	burden	NOUN
dpc-2702	46	8	ad	ad	NOUN
dpc-2702	46	9	,	,	PUNCT
dpc-2702	46	10	capon	capon	NOUN
dpc-2702	46	11	f	f	PROPN
dpc-2702	46	12	,	,	PUNCT
dpc-2702	46	13	et	et	PROPN
dpc-2702	46	14	al	al	PROPN
dpc-2702	46	15	.	.	PUNCT
dpc-2702	47	1	european	european	ADJ
dpc-2702	47	2	consensus	consensus	NOUN
dpc-2702	47	3	statement	statement	NOUN
dpc-2702	47	4	on	on	ADP
dpc-2702	47	5	phenotypes	phenotype	NOUN
dpc-2702	47	6	of	of	ADP
dpc-2702	47	7	pustular	pustular	ADJ
dpc-2702	47	8	psoriasis	psoriasis	NOUN
dpc-2702	47	9	.	.	PUNCT
dpc-2702	48	1	j	j	PROPN
dpc-2702	48	2	eur	eur	PROPN
dpc-2702	48	3	acad	acad	PROPN
dpc-2702	48	4	dermatol	dermatol	NOUN
dpc-2702	48	5	venereol	venereol	NOUN
dpc-2702	48	6	.	.	PUNCT
dpc-2702	49	1	2017;31(11):1792	2017;31(11):1792	NUM
dpc-2702	49	2	-	-	SYM
dpc-2702	49	3	1799	1799	NUM
dpc-2702	49	4	.	.	PUNCT
dpc-2702	50	1	doi:10.1111	doi:10.1111	ADJ
dpc-2702	50	2	/	/	SYM
dpc-2702	50	3	jdv	jdv	NOUN
dpc-2702	50	4	.14386	.14386	PROPN
dpc-2702	50	5	.	.	PUNCT
dpc-2702	51	1	pmid	pmid	NOUN
dpc-2702	51	2	:	:	PUNCT
dpc-2702	51	3	28585342	28585342	NUM
dpc-2702	51	4	.	.	PUNCT
dpc-2702	52	1	figure	figure	NOUN
dpc-2702	52	2	1	1	NUM
dpc-2702	52	3	.	.	PUNCT
dpc-2702	53	1	(	(	PUNCT
dpc-2702	53	2	a	a	DET
dpc-2702	53	3	,	,	PUNCT
dpc-2702	53	4	b	b	NOUN
dpc-2702	53	5	)	)	PUNCT
dpc-2702	53	6	sterile	sterile	ADJ
dpc-2702	53	7	pustules	pustule	NOUN
dpc-2702	53	8	on	on	ADP
dpc-2702	53	9	erythematous	erythematous	ADJ
dpc-2702	53	10	skin	skin	NOUN
dpc-2702	53	11	with	with	ADP
dpc-2702	53	12	moderate	moderate	ADJ
dpc-2702	53	13	scaling	scaling	NOUN
dpc-2702	53	14	on	on	ADP
dpc-2702	53	15	the	the	DET
dpc-2702	53	16	left	left	ADJ
dpc-2702	53	17	foot	foot	NOUN
dpc-2702	53	18	(	(	PUNCT
dpc-2702	53	19	a	a	NOUN
dpc-2702	53	20	)	)	PUNCT
dpc-2702	53	21	and	and	CCONJ
dpc-2702	53	22	on	on	ADP
dpc-2702	53	23	the	the	DET
dpc-2702	53	24	right	right	ADJ
dpc-2702	53	25	palm	palm	NOUN
dpc-2702	53	26	(	(	PUNCT
dpc-2702	53	27	b	b	NOUN
dpc-2702	53	28	)	)	PUNCT
dpc-2702	53	29	of	of	ADP
dpc-2702	53	30	a	a	DET
dpc-2702	53	31	32	32	NUM
dpc-2702	53	32	-	-	PUNCT
dpc-2702	53	33	year	year	NOUN
dpc-2702	53	34	-	-	PUNCT
dpc-2702	53	35	old	old	ADJ
dpc-2702	53	36	woman	woman	NOUN
dpc-2702	53	37	,	,	PUNCT
dpc-2702	53	38	before	before	ADP
dpc-2702	53	39	the	the	DET
dpc-2702	53	40	start	start	NOUN
dpc-2702	53	41	of	of	ADP
dpc-2702	53	42	the	the	DET
dpc-2702	53	43	therapy	therapy	NOUN
dpc-2702	53	44	.	.	PUNCT
dpc-2702	54	1	figure	figure	NOUN
dpc-2702	54	2	2	2	NUM
dpc-2702	54	3	.	.	PUNCT
dpc-2702	55	1	(	(	PUNCT
dpc-2702	55	2	a	a	DET
dpc-2702	55	3	,	,	PUNCT
dpc-2702	55	4	b	b	NOUN
dpc-2702	55	5	)	)	PUNCT
dpc-2702	55	6	clinical	clinical	ADJ
dpc-2702	55	7	appearance	appearance	NOUN
dpc-2702	55	8	of	of	ADP
dpc-2702	55	9	the	the	DET
dpc-2702	55	10	patient	patient	ADJ
dpc-2702	55	11	soles	sol	NOUN
dpc-2702	55	12	(	(	PUNCT
dpc-2702	55	13	a	a	NOUN
dpc-2702	55	14	)	)	PUNCT
dpc-2702	55	15	and	and	CCONJ
dpc-2702	55	16	palms	palm	NOUN
dpc-2702	55	17	(	(	PUNCT
dpc-2702	55	18	b	b	NOUN
dpc-2702	55	19	)	)	PUNCT
dpc-2702	55	20	after	after	ADP
dpc-2702	55	21	28	28	NUM
dpc-2702	55	22	weeks	week	NOUN
dpc-2702	55	23	of	of	ADP
dpc-2702	55	24	therapy	therapy	NOUN
dpc-2702	55	25	with	with	ADP
dpc-2702	55	26	risankizumab	risankizumab	NOUN
dpc-2702	55	27	.	.	PUNCT
dpc-2702	56	1	complete	complete	ADJ
dpc-2702	56	2	resolution	resolution	NOUN
dpc-2702	56	3	of	of	ADP
dpc-2702	56	4	the	the	DET
dpc-2702	56	5	pustules	pustule	NOUN
dpc-2702	56	6	is	be	AUX
dpc-2702	56	7	observed	observe	VERB
dpc-2702	56	8	,	,	PUNCT
dpc-2702	56	9	with	with	ADP
dpc-2702	56	10	the	the	DET
dpc-2702	56	11	persistence	persistence	NOUN
dpc-2702	56	12	of	of	ADP
dpc-2702	56	13	only	only	ADJ
dpc-2702	56	14	slight	slight	ADJ
dpc-2702	56	15	erythema	erythema	NOUN
dpc-2702	56	16	and	and	CCONJ
dpc-2702	56	17	scaling	scaling	NOUN
dpc-2702	56	18	.	.	PUNCT
dpc-2702	57	1	research	research	NOUN
dpc-2702	57	2	letter	letter	NOUN
dpc-2702	57	3	|	|	ADV
dpc-2702	57	4	dermatol	dermatol	ADJ
dpc-2702	57	5	pract	pract	NOUN
dpc-2702	57	6	concept	concept	NOUN
dpc-2702	57	7	.	.	PUNCT
dpc-2702	58	1	2023;13(2):e2023097	2023;13(2):e2023097	NUM
dpc-2702	58	2	3	3	NUM
dpc-2702	58	3	2	2	NUM
dpc-2702	58	4	.	.	PUNCT
dpc-2702	58	5	uppala	uppala	NOUN
dpc-2702	58	6	r	r	NOUN
dpc-2702	58	7	,	,	PUNCT
dpc-2702	58	8	tsoi	tsoi	PROPN
dpc-2702	58	9	lc	lc	PROPN
dpc-2702	58	10	,	,	PUNCT
dpc-2702	58	11	harms	harm	VERB
dpc-2702	58	12	pw	pw	PROPN
dpc-2702	58	13	,	,	PUNCT
dpc-2702	58	14	et	et	PROPN
dpc-2702	58	15	al	al	PROPN
dpc-2702	58	16	.	.	PUNCT
dpc-2702	59	1	“	"	PUNCT
dpc-2702	59	2	autoinflammatory	autoinflammatory	ADJ
dpc-2702	59	3	psoriasis”-genetics	psoriasis”-genetic	NOUN
dpc-2702	59	4	and	and	CCONJ
dpc-2702	59	5	biology	biology	NOUN
dpc-2702	59	6	of	of	ADP
dpc-2702	59	7	pustular	pustular	ADJ
dpc-2702	59	8	psoriasis	psoriasis	NOUN
dpc-2702	59	9	.	.	PUNCT
dpc-2702	60	1	cell	cell	NOUN
dpc-2702	60	2	mol	mol	ADP
dpc-2702	60	3	immunol	immunol	NOUN
dpc-2702	60	4	.	.	PUNCT
dpc-2702	61	1	2021;18(2):307	2021;18(2):307	NUM
dpc-2702	61	2	-	-	PUNCT
dpc-2702	61	3	317	317	NUM
dpc-2702	61	4	.	.	PUNCT
dpc-2702	61	5	doi:10.1038	doi:10.1038	NOUN
dpc-2702	61	6	/	/	SYM
dpc-2702	61	7	s41423	s41423	PROPN
dpc-2702	61	8	-	-	PUNCT
dpc-2702	61	9	020	020	NUM
dpc-2702	61	10	-	-	PUNCT
dpc-2702	61	11	0519	0519	NUM
dpc-2702	61	12	-	-	PUNCT
dpc-2702	61	13	3	3	NUM
dpc-2702	61	14	.	.	PUNCT
dpc-2702	61	15	pmid	pmid	NOUN
dpc-2702	61	16	:	:	PUNCT
dpc-2702	61	17	32814870	32814870	NUM
dpc-2702	61	18	.	.	PUNCT
dpc-2702	62	1	pmcid	pmcid	NOUN
dpc-2702	62	2	:	:	PUNCT
dpc-2702	62	3	pmc8027616	pmc8027616	NOUN
dpc-2702	62	4	.	.	PUNCT
dpc-2702	63	1	3	3	X
dpc-2702	63	2	.	.	X
dpc-2702	63	3	wang	wang	PROPN
dpc-2702	63	4	wm	wm	PROPN
dpc-2702	63	5	,	,	PUNCT
dpc-2702	63	6	jin	jin	PROPN
dpc-2702	63	7	hz	hz	PROPN
dpc-2702	63	8	.	.	PROPN
dpc-2702	63	9	biologics	biologic	NOUN
dpc-2702	63	10	in	in	ADP
dpc-2702	63	11	the	the	DET
dpc-2702	63	12	treatment	treatment	NOUN
dpc-2702	63	13	of	of	ADP
dpc-2702	63	14	pustular	pustular	ADJ
dpc-2702	63	15	psoriasis	psoriasis	NOUN
dpc-2702	63	16	.	.	PUNCT
dpc-2702	64	1	expert	expert	NOUN
dpc-2702	64	2	opin	opin	NOUN
dpc-2702	64	3	drug	drug	NOUN
dpc-2702	64	4	saf	saf	PROPN
dpc-2702	64	5	.	.	PUNCT
dpc-2702	65	1	2020;19(8):969	2020;19(8):969	NUM
dpc-2702	65	2	-	-	PUNCT
dpc-2702	65	3	980	980	NUM
dpc-2702	65	4	.	.	PUNCT
dpc-2702	66	1	doi:10.1080	doi:10.1080	NOUN
dpc-2702	66	2	/14740338.2020.1785427	/14740338.2020.1785427	PROPN
dpc-2702	66	3	.	.	PUNCT
dpc-2702	67	1	pmid	pmid	NOUN
dpc-2702	67	2	:	:	PUNCT
dpc-2702	67	3	32615817	32615817	NUM
dpc-2702	67	4	.	.	PUNCT
dpc-2702	68	1	4	4	X
dpc-2702	68	2	.	.	X
dpc-2702	68	3	mrowietz	mrowietz	PROPN
dpc-2702	68	4	u	u	NOUN
dpc-2702	68	5	,	,	PUNCT
dpc-2702	68	6	bachelez	bachelez	PROPN
dpc-2702	68	7	h	h	NOUN
dpc-2702	68	8	,	,	PUNCT
dpc-2702	68	9	burden	burden	NOUN
dpc-2702	68	10	ad	ad	NOUN
dpc-2702	68	11	,	,	PUNCT
dpc-2702	68	12	et	et	PROPN
dpc-2702	68	13	al	al	PROPN
dpc-2702	68	14	.	.	PROPN
dpc-2702	68	15	secukinumab	secukinumab	PROPN
dpc-2702	68	16	for	for	ADP
dpc-2702	68	17	moderate	moderate	ADJ
dpc-2702	68	18	-	-	PUNCT
dpc-2702	68	19	to	to	ADP
dpc-2702	68	20	-	-	PUNCT
dpc-2702	68	21	severe	severe	ADJ
dpc-2702	68	22	palmoplantar	palmoplantar	NOUN
dpc-2702	68	23	pustular	pustular	ADJ
dpc-2702	68	24	psoriasis	psoriasis	NOUN
dpc-2702	68	25	:	:	PUNCT
dpc-2702	68	26	results	result	NOUN
dpc-2702	68	27	of	of	ADP
dpc-2702	68	28	the	the	DET
dpc-2702	68	29	2precise	2precise	PROPN
dpc-2702	68	30	study	study	NOUN
dpc-2702	68	31	.	.	PUNCT
dpc-2702	69	1	j	j	PROPN
dpc-2702	69	2	am	be	AUX
dpc-2702	69	3	acad	acad	ADJ
dpc-2702	69	4	dermatol	dermatol	NOUN
dpc-2702	69	5	.	.	PUNCT
dpc-2702	70	1	2019;80(5	2019;80(5	NUM
dpc-2702	70	2	):	):	PUNCT
dpc-2702	70	3	1344	1344	NUM
dpc-2702	70	4	-	-	SYM
dpc-2702	70	5	1352	1352	NUM
dpc-2702	70	6	.	.	PUNCT
dpc-2702	71	1	doi:10.1016	doi:10.1016	PROPN
dpc-2702	71	2	/	/	SYM
dpc-2702	71	3	j.jaad.2019.01.066	j.jaad.2019.01.066	PROPN
dpc-2702	71	4	.	.	PUNCT
dpc-2702	72	1	pmid	pmid	NOUN
dpc-2702	72	2	:	:	PUNCT
dpc-2702	72	3	30716404	30716404	NUM
dpc-2702	72	4	.	.	PUNCT
dpc-2702	73	1	5	5	X
dpc-2702	73	2	.	.	X
dpc-2702	73	3	borroni	borroni	PROPN
dpc-2702	73	4	rg	rg	PROPN
dpc-2702	73	5	,	,	PUNCT
dpc-2702	73	6	malagoli	malagoli	NOUN
dpc-2702	73	7	p	p	NOUN
dpc-2702	73	8	,	,	PUNCT
dpc-2702	73	9	gargiulo	gargiulo	NOUN
dpc-2702	73	10	l	l	NOUN
dpc-2702	73	11	,	,	PUNCT
dpc-2702	73	12	et	et	PROPN
dpc-2702	73	13	al	al	PROPN
dpc-2702	73	14	.	.	PUNCT
dpc-2702	74	1	real	real	ADJ
dpc-2702	74	2	-	-	PUNCT
dpc-2702	74	3	life	life	NOUN
dpc-2702	74	4	effectiveness	effectiveness	NOUN
dpc-2702	74	5	and	and	CCONJ
dpc-2702	74	6	safety	safety	NOUN
dpc-2702	74	7	of	of	ADP
dpc-2702	74	8	risankizumab	risankizumab	NOUN
dpc-2702	74	9	in	in	ADP
dpc-2702	74	10	moderate	moderate	ADJ
dpc-2702	74	11	-	-	PUNCT
dpc-2702	74	12	to	to	ADP
dpc-2702	74	13	-	-	PUNCT
dpc-2702	74	14	severe	severe	ADJ
dpc-2702	74	15	plaque	plaque	NOUN
dpc-2702	74	16	psoriasis	psoriasis	NOUN
dpc-2702	74	17	:	:	PUNCT
dpc-2702	74	18	a	a	DET
dpc-2702	74	19	40	40	NUM
dpc-2702	74	20	-	-	PUNCT
dpc-2702	74	21	week	week	NOUN
dpc-2702	74	22	multicentric	multicentric	ADJ
dpc-2702	74	23	retrospective	retrospective	ADJ
dpc-2702	74	24	study	study	NOUN
dpc-2702	74	25	.	.	PUNCT
dpc-2702	75	1	acta	acta	PROPN
dpc-2702	75	2	derm	derm	PROPN
dpc-2702	75	3	venereol	venereol	NOUN
dpc-2702	75	4	.	.	PUNCT
dpc-2702	76	1	2021;101(11):adv00605	2021;101(11):adv00605	X
dpc-2702	76	2	.	.	PUNCT
dpc-2702	77	1	doi:10.2340	doi:10.2340	PROPN
dpc-2702	77	2	/	/	SYM
dpc-2702	77	3	actadv	actadv	PROPN
dpc-2702	77	4	.v101.283	.v101.283	X
dpc-2702	77	5	.	.	PUNCT
dpc-2702	78	1	pmid	pmid	NOUN
dpc-2702	78	2	:	:	PUNCT
dpc-2702	78	3	34596230	34596230	NUM
dpc-2702	78	4	.	.	PUNCT
dpc-2702	79	1	pmcid	pmcid	NOUN
dpc-2702	79	2	:	:	PUNCT
dpc-2702	79	3	pmc9455321	pmc9455321	ADJ
dpc-2702	79	4	.	.	PUNCT
dpc-2702	80	1	6	6	X
dpc-2702	80	2	.	.	X
dpc-2702	80	3	gargiulo	gargiulo	PROPN
dpc-2702	80	4	l	l	NOUN
dpc-2702	80	5	,	,	PUNCT
dpc-2702	80	6	pavia	pavia	PROPN
dpc-2702	80	7	g	g	PROPN
dpc-2702	80	8	,	,	PUNCT
dpc-2702	80	9	valenti	valenti	PROPN
dpc-2702	80	10	m	m	PROPN
dpc-2702	80	11	,	,	PUNCT
dpc-2702	80	12	et	et	PROPN
dpc-2702	80	13	al	al	PROPN
dpc-2702	80	14	.	.	PROPN
dpc-2702	80	15	safety	safety	NOUN
dpc-2702	80	16	of	of	ADP
dpc-2702	80	17	biologic	biologic	NOUN
dpc-2702	80	18	therapies	therapy	NOUN
dpc-2702	80	19	in	in	ADP
dpc-2702	80	20	patients	patient	NOUN
dpc-2702	80	21	with	with	ADP
dpc-2702	80	22	moderate	moderate	ADJ
dpc-2702	80	23	-	-	PUNCT
dpc-2702	80	24	to	to	ADP
dpc-2702	80	25	-	-	PUNCT
dpc-2702	80	26	severe	severe	ADJ
dpc-2702	80	27	plaque	plaque	NOUN
dpc-2702	80	28	psoriasis	psoriasis	NOUN
dpc-2702	80	29	and	and	CCONJ
dpc-2702	80	30	concomitant	concomitant	ADJ
dpc-2702	80	31	viral	viral	ADJ
dpc-2702	80	32	hepatitis	hepatitis	NOUN
dpc-2702	80	33	:	:	PUNCT
dpc-2702	80	34	a	a	DET
dpc-2702	80	35	monocentric	monocentric	ADJ
dpc-2702	80	36	retrospective	retrospective	ADJ
dpc-2702	80	37	study	study	NOUN
dpc-2702	80	38	.	.	PUNCT
dpc-2702	81	1	dermatol	dermatol	NOUN
dpc-2702	81	2	ther	ther	ADV
dpc-2702	81	3	(	(	PUNCT
dpc-2702	81	4	heidelb	heidelb	NOUN
dpc-2702	81	5	)	)	PUNCT
dpc-2702	81	6	.	.	PUNCT
dpc-2702	82	1	2022;12(5):1263	2022;12(5):1263	NUM
dpc-2702	82	2	-	-	SYM
dpc-2702	82	3	1270	1270	NUM
dpc-2702	82	4	.	.	PUNCT
dpc-2702	83	1	doi:10.1007	doi:10.1007	PROPN
dpc-2702	83	2	/	/	SYM
dpc-2702	83	3	s13555	s13555	PROPN
dpc-2702	83	4	-	-	PUNCT
dpc-2702	83	5	022	022	NUM
dpc-2702	83	6	-	-	PUNCT
dpc-2702	83	7	00726	00726	NUM
dpc-2702	83	8	-	-	PUNCT
dpc-2702	83	9	w.	w.	NOUN
dpc-2702	83	10	pmid	pmid	PROPN
dpc-2702	83	11	:	:	PUNCT
dpc-2702	83	12	35460018	35460018	NUM
dpc-2702	83	13	.	.	PUNCT
dpc-2702	84	1	pmcid	pmcid	ADJ
dpc-2702	84	2	:	:	PUNCT
dpc-2702	84	3	pmc9110615	pmc9110615	NOUN
dpc-2702	84	4	.	.	PUNCT